Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

14.80
BATS BZX Real-Time Price
As of 3:13pm ET
 +0.09 / +0.61%
Today’s Change
14.30
Today|||52-Week Range
44.42
-59.17%
Year-to-Date
Zacks Industry Outlook Highlights: Gilead, Teva, Pfizer and Amgen
10:19am / Zacks.com - Paid Partner Content
Trump Hits Pharma
Oct 16 / TheStreet.com - Paid Partner Content
Chickasaw Capital Management Llc Buys DowDuPont Inc, Bank of America Corporation, Ban...
Oct 16 / GuruFocus News - Paid Partner Content
3 Biotech Values in a Fully Valued Market
Oct 15 / TheStreet.com - Paid Partner Content
Iowa State Bank Buys Shire PLC, Workiva Inc, BioTime Inc, Sells E.I. ...
Oct 16 / GuruFocus News - Paid Partner Content
3 Biotech Values in a Fully Valued Market
Oct 13 / TheStreet.com - Paid Partner Content
Pharma Industry Outlook - October 2017
Oct 16 / Zacks.com - Paid Partner Content
Bridge Creek Capital Management LLC Buys DowDuPont Inc, Henry Schein Inc, Ormat Techn...
Oct 12 / GuruFocus News - Paid Partner Content
Iowa State Bank Buys Shire PLC, Workiva Inc, BioTime Inc, Sells E.I. ...
Oct 16 / GuruFocus News - Paid Partner Content
Mylan Gets Complete Response Letter For Biosimilar Neulasta
Oct 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close14.71
Today’s open14.78
Day’s range14.59 - 14.97
Volume532,573
Average volume (3 months)19,205,260
Market cap$14.9B
Dividend yield7.47%
Data as of 3:13pm ET, 10/17/2017

Growth & Valuation

Earnings growth (last year)-96.18%
Earnings growth (this year)-17.52%
Earnings growth (next 5 years)-0.30%
Revenue growth (last year)+12.01%
P/E ratioNM
Price/Sales1.59
Price/Book0.50

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd-5.44-5.80%
TYMETyme Technologies In...-0.04-0.95%
OASMOasmia Pharmaceutica...-0.04-4.00%
Data as of 3:09pm ET, 10/17/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$1.07
Annual revenue (last year)$22.0B
Annual profit (last year)$330.0M
Net profit margin1.50%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President &
Chief Executive Officer
Kåre Schultz
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts